SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

BioCardia, Inc. – ‘8-A12B’ on 7/23/19

On:  Tuesday, 7/23/19, at 4:34pm ET   ·   Accession #:  1437749-19-14460   ·   File #:  1-38999

9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/23/19  BioCardia, Inc.                   8-A12B                 1:19K                                    RDG Filings/FA

Registration of a Class of Securities   —   Form 8-A   —   Sect. 12(b) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B      Registration of a Class of Securities               HTML     12K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <>  <> 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

BioCardia, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware

 

47-0892881

(State of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

125 Shoreway Road, Suite B,

San Carlos, California 94070

(Address of principal executive offices including zip code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

 Title of each class to be so registered

 

 Name of each exchange on which each

class is to be registered

Common Stock, par value $0.001 per share

Warrants, exercisable for shares of

Common Stock

 

The Nasdaq Stock Market LLC

 

The Nasdaq Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates: Registration Statement No. 333-230779

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered

 

BioCardia, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock, par value $0.001 per share and the warrants exercisable for shares of such common stock, to be registered hereunder contained under the heading “Description of the Securities We Are Offering” in the prospectus forming part of the Registrant’s Registration Statement on Form S-1 (File No. 333-230779), initially filed with the Securities and Exchange Commission (the “Commission”) on April 8, 2019, as amended from time to time (the “Registration Statement”). In addition, any prospectus subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, that constitutes part of the Registration Statement shall be deemed to be incorporated by reference herein.

 

Item 2. Exhibits

 

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

BIOCARDIA, INC.

 
       

Date: July 23, 2019

By:

/s/ Peter Altman, Ph.D.

 
   

Peter Altman, Ph.D. 

 
   

Chief Executive Officer

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-A12B’ Filing    Date    Other Filings
Filed on:7/23/19S-1/A
4/8/19
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/24  BioCardia, Inc.                   S-3                    4:237K                                   RDG Filings/FA
11/17/23  BioCardia, Inc.                   424B5                  1:459K                                   RDG Filings/FA
 6/22/23  BioCardia, Inc.                   424B5                  1:431K                                   RDG Filings/FA
12/19/22  BioCardia, Inc.                   S-3        12/16/22    4:247K                                   RDG Filings/FA
 4/12/22  BioCardia, Inc.                   424B5                  1:422K                                   RDG Filings/FA
 3/30/21  BioCardia, Inc.                   424B5                  1:1.1M                                   RDG Filings/FA
12/16/20  BioCardia, Inc.                   424B5                  1:466K                                   RDG Filings/FA
12/15/20  BioCardia, Inc.                   424B5                  1:463K                                   RDG Filings/FA
10/09/20  BioCardia, Inc.                   S-3                    5:1.4M                                   RDG Filings/FA
Top
Filing Submission 0001437749-19-014460   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 9:40:15.2am ET